CClinicalTrials.gg
Status unknownNCT05535985Updated Sep 14, 2022

Study of Acupuncture on Postoperative Delirium in Patients With Diabetes Mellitus

An interventional study of acupuncture and placebo acupuncture in Acupuncture, Postoperative Delirium (POD) and Diabetes Mellitus, sponsored by Lingling Ding. Status unknown. Open to participants aged 30 Years to 80 Years. Per ClinicalTrials.gov, last updated 2022-09-14.

Sponsored by Lingling Ding · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Sep 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
215
Allocation
Randomized
Ages
30 Years to 80 Years
Sex
All
01

Study summary

  1. To evaluate the effectiveness and safety of acupuncture on POD in diabetic patients undergoing surgery, to provide effective prevention and treatment measures of integrated traditional Chinese and western medicine for reducing the incidence of postoperative delirium in high-risk groups, and to provide clinical basis for further promotion of integrated traditional Chinese and western medicine anesthesia in the future.
  2. To investigate the relationship between POD and rSO2 in diabetic patients undergoing surgery. To clarify the predictive value of intraoperative rSO2 monitoring on postoperative cognitive function in patients with diabetes, and to explore the effect of acupuncture on cerebral blood flow perfusion in patients with diabetes.
Read the detailed description

Postoperative delirium (POD) increases the risk of postoperative dementia and mortality. Cognitive decline is common in patients with diabetes mellitus. As an independent risk factor for POD, diabetes significantly increases postoperative dementia and mortality. Our team found that acupuncture can reduce the incidence of POD in elderly patients, increase regional cerebral oxygen saturation (rSO2), and increase cerebral blood flow perfusion in diabetic patients. In this study, a prospective randomized controlled study with placebo acupuncture will be conducted. Diabetic patients undergoing elective surgery will be divided into acupuncture group, placebo acupuncture group and control group. Acupuncture will be used as the intervention method, and the incidence of POD will be the main therapeutic effect evaluation index to explore the efficacy of acupuncture in the prevention and treatment of POD in diabetic patients undergoing surgery.

02

Conditions studied

  • Acupuncture
  • Postoperative Delirium (POD)
  • Diabetes Mellitus

Keywords

  • Acupuncture
  • Postoperative delirium (POD)
  • Diabetes Mellitus
  • Regional Cerebral Oxygen Saturation (rSO2)
03

In context

Delirium

1,057 studies on the registry are indexed under Delirium; 238 are open to participants now.

This study's planned enrollment of 215 is above the median of 120 across 599 interventional studies indexed under Delirium.

Browse Delirium studies →

Lead sponsor

Lingling Ding is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients undergoing general anesthesia in our hospital
  • Expected duration of operation >2h
  • Ages 18-60
  • With type 2 diabetes
  • American Society of Anesthesiologists (ASA) grade 2-3 , no severe respiratory, circulation, liver, kidney, coagulation function abnormalities;
  • Expected postoperative hospital stay >3 days
  • No history of cerebrovascular accident in the past six months
  • The informed consent signed

Exclusion criteria

Exclusion Criteria:

  • Unable or unwilling to cooperate with cognitive function scale tests
  • MMSE score \<24
  • Refuse acupuncture treatment or have a history of needle sickness
  • With skin damage at the acupuncture sites
  • Coagulation dysfunction
  • Participated in other clinical studies
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
215 participants (estimated)

Study arms

  • Experimental
    acupuncture group

    In the acupuncture group, acupoints of Baihui, Shenting, Sishencong will be selected for acupuncture stimulation be anesthesia. The needle will be kept for 30 minutes, during which the needle will be performed once every 10 minutes for 10 seconds each time, 4 times in total. The therapist will give the subject verbal cues before and during the needle manipulation.

    Device: acupuncture

  • Placebo comparator
    placebo acupuncture group

    The patients will be treated with consolation needle. Choose treatment of points that near but without going through the acupoints(upper arm deltoid muscle). Use the Park needle (blunt needle, tip obtuse, when acupuncture the feeling is similar to acupuncture needles into the skin, but it retracts instead of piercing the skin) to conduct acupuncture treatment. The retention time and number of needles will be the same as those in the acupuncture group. The therapist will give the subjects verbal cues before and during the acupuncture manipulation, which further reduces the subjects' doubts about the authenticity of acupuncture in the this group. To ensure the implementation of the blinding method, all patients will be treated independently and avoid contacting with each other.

    Device: placebo acupuncture

  • No intervention
    control group

    The patients will undergoing routine anesthesia without acupuncture treatment.

Interventions

  • Deviceacupuncture

    treatment of pain or disease by inserting the tips of needles at specific points on the skin

  • Deviceplacebo acupuncture

    placebo acupuncture

06

What researchers measure

Primary outcomes

  1. Incidence of postoperative delirium

    assess the incidence of postoperative delirium using the 3-minute diagnostic confusion assessment method (3D-CAM)

    Time frame: at 8 a.m. the day after surgery

  2. Incidence of postoperative delirium

    assess the incidence of postoperative delirium using 3D-CAM

    Time frame: at 16 p.m. the day after surgery

  3. Incidence of postoperative delirium

    assess the incidence of postoperative delirium using 3D-CAM

    Time frame: at 8 a.m. the second day after surgery

  4. Incidence of postoperative delirium

    assess the incidence of postoperative delirium using 3D-CAM

    Time frame: at 16 p.m. the second day after surgery

  5. Incidence of postoperative delirium

    assess the incidence of postoperative delirium using 3D-CAM

    Time frame: at 8 a.m. the third day after surgery

  6. Incidence of postoperative delirium

    assess the incidence of postoperative delirium using 3D-CAM

    Time frame: at 16 p.m. the third day after surgery

Secondary outcomes

  1. Regional Saturation of Oxygenation (rSO2)

    The brain oxygen saturation monitoring electrode was attached to the forehead, and the baseline level (T0) was recorded after the reading was stable under the condition of air inhalation. rSO2 readings were recorded after induction (T1), at the beginning of surgery (T2), one hour after the beginning of surgery (T3), at the end of surgery (T4), and after extubation (T5). The maximum and minimum values of rSO2 readings during surgery were recorded, and the area under the rSO2 curve was recorded when the rSO2 reading decreased by 13% from baseline for more than 5 minutes. rSO2 values of each time point, maximum and minimum values during surgery.

    Time frame: baseline

  2. Regional Saturation of Oxygenation (rSO2)

    The brain oxygen saturation monitoring electrode was attached to the forehead, and the baseline level (T0) was recorded after the reading was stable under the condition of air inhalation. rSO2 readings were recorded after induction (T1), at the beginning of surgery (T2), one hour after the beginning of surgery (T3), at the end of surgery (T4), and after extubation (T5). The maximum and minimum values of rSO2 readings during surgery were recorded, and the area under the rSO2 curve was recorded when the rSO2 reading decreased by 13% from baseline for more than 5 minutes. rSO2 values of each time point, maximum and minimum values during surgery.

    Time frame: the time when tracheal intubation finished

  3. Regional Saturation of Oxygenation (rSO2)

    The brain oxygen saturation monitoring electrode was attached to the forehead, and the baseline level (T0) was recorded after the reading was stable under the condition of air inhalation. rSO2 readings were recorded after induction (T1), at the beginning of surgery (T2), one hour after the beginning of surgery (T3), at the end of surgery (T4), and after extubation (T5). The maximum and minimum values of rSO2 readings during surgery were recorded, and the area under the rSO2 curve was recorded when the rSO2 reading decreased by 13% from baseline for more than 5 minutes. rSO2 values of each time point, maximum and minimum values during surgery.

    Time frame: the time when the surgery begins

  4. Regional Saturation of Oxygenation (rSO2)

    The brain oxygen saturation monitoring electrode was attached to the forehead, and the baseline level (T0) was recorded after the reading was stable under the condition of air inhalation. rSO2 readings were recorded after induction (T1), at the beginning of surgery (T2), one hour after the beginning of surgery (T3), at the end of surgery (T4), and after extubation (T5). The maximum and minimum values of rSO2 readings during surgery were recorded, and the area under the rSO2 curve was recorded when the rSO2 reading decreased by 13% from baseline for more than 5 minutes. rSO2 values of each time point, maximum and minimum values during surgery.

    Time frame: 1 hour after the beginning of the surgery

  5. Regional Saturation of Oxygenation (rSO2)

    The brain oxygen saturation monitoring electrode was attached to the forehead, and the baseline level (T0) was recorded after the reading was stable under the condition of air inhalation. rSO2 readings were recorded after induction (T1), at the beginning of surgery (T2), one hour after the beginning of surgery (T3), at the end of surgery (T4), and after extubation (T5). The maximum and minimum values of rSO2 readings during surgery were recorded, and the area under the rSO2 curve was recorded when the rSO2 reading decreased by 13% from baseline for more than 5 minutes. rSO2 values of each time point, maximum and minimum values during surgery.

    Time frame: the time when the surgery ends

  6. Regional Saturation of Oxygenation (rSO2)

    The brain oxygen saturation monitoring electrode was attached to the forehead, and the baseline level (T0) was recorded after the reading was stable under the condition of air inhalation. rSO2 readings were recorded after induction (T1), at the beginning of surgery (T2), one hour after the beginning of surgery (T3), at the end of surgery (T4), and after extubation (T5). The maximum and minimum values of rSO2 readings during surgery were recorded, and the area under the rSO2 curve was recorded when the rSO2 reading decreased by 13% from baseline for more than 5 minutes. rSO2 values of each time point, maximum and minimum values during surgery.

    Time frame: Intraoperative

  7. Visual Analogue Score (VAS)

    Record VAS. VAS is a psychometric response score. Draw a 10 cm horizontal line on the paper. The end of the line is 0, indicating no pain; the other end is 10, indicating severe pain. The middle part shows different levels of pain.

    Time frame: at 8 a.m. and 16 p.m. daily for 3 days after surgery

  8. Blood glucose levels

    record blood glucose levels

    Time frame: Entering the operating room, the time when the surgery ends

  9. Expression of reactive oxygen species (ROS), superoxide dismutase (SOD), S100β in serum

    The inflammation level will be assessed.

    Time frame: Entering the operating room, the time when the surgery ends

  10. Expression of peroxisome proliferators-activated receptor-γcoactivator-1α (PGC-1α)

    assess the expression of PGC-1α

    Time frame: Entering the operating room, the time when the surgery ends

Other outcomes

  1. Height

    Record the height (in meters) of the patient

    Time frame: The 1 day before surgery

  2. Weight

    Record the weight (in kilograms) of the patient

    Time frame: The 1 day before surgery

  3. Mini-mental state examination (MMSE) score

    Scores are measured by the MMSE, with a maximum score of 30, a score between 27 and 30 is considered normal cognitive function, and a score less than 27 is considered cognitive dysfunction.

    Time frame: The 1 day before surgery

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 14, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05535985
Lead sponsor
Lingling Ding
Responsible party
Lingling Ding (Professor, Beijing Hospital of Traditional Chinese Medicine) — Sponsor-investigator
First posted
Sep 10, 2022
Start date
Jan 1, 2023 (estimated)
Primary completion
Dec 31, 2023 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
Sep 14, 2022

Study contacts

Lingling Ding, Doctor
Contact
dinglingling301@126.com
+86 010 87906647
Ruiling Zhou, Master
Contact
1652282940@qq.com
+86 010 87906647
Lingling Ding, Doctor
principal investigator · Beijing Hospital of Traditional Chinese Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion